A study published recently in the Journal of American Medical Association (JAMA), also points to this. This study found that use of GLP-1 agonists for weight loss compared with use of other weight-loss drugs was associated with increased risk of pancreatitis, gastroparesis, and bowel obstruction, but not biliary disease., A study published recently in the Journal of American Medical Association (JAMA), also points to this. This study found that use of GLP-1 agonists for weight loss compared with use of other weight-loss drugs was associated with increased risk of pancreatitis, gastroparesis, and bowel obstruction, but not biliary disease., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way